Staging breast cancer with PET/MRI

Accurate staging of breast cancer prior to neoadjuvant chemotherapy is important for individualised radiotherapy planning. A scientific team evaluated the clinical value of 18F-fluorodeoxyglucose with hybrid PET/MRI compared with standard-of-care imaging (digital mammography, ultrasound, MRI) for loco-regional staging of patients with breast cancer prior to neoadjuvant chemotherapy.
Medscape